University of Newcastle homepage

Professor

Eugenie Lumbers

Honorary Professor

School of Biomedical Sciences and Pharmacy

Orcid identifier0000-0003-3945-3923
  • Honorary Professor
    School of Biomedical Sciences and Pharmacy

BIOGRAPHY

ACADEMIC QUALIFICATIONS: MBBS  (Adel, 1965); MD (Adel, 1970); DSc (UNSW, 1986).

 

CURRENT APPOINTMENT/S: Current positions; Conjoint Professor UNSW 2003-2013; Conjoint Professor University of Queensland, 2009-2011; Professorial appointment; University of Newcastle (continuing). 

 

HONOURS AND AWARDS:

1972-1974: C.J. Martin Travelling Fellowship (NHMRC); first woman;

1988: awarded a personal chair in physiology at UNSW on basis of research achievements.

1998: Scientia  Professor (first cohort; first woman; for research);

2002: Fellow Australian Academy of Science;

2002: Life Membership of the Australian Physiological Society;

2002: Centenary Medal of Federation, Australia..

2001: Fellow of the Royal Society of NSW. 

2012: Order of Australia (general division).

 

NATIONAL AND INTERNATIONAL PROFILE:

Having completed her medical degree, Eugenie Lumbers decided on a career in medical research.
She began her research under the supervision of Sandford Skinner. Asa graduate student enrolled for the degree of Doctor in Medicine, she showed that renal excretion of renin was low and that contamination by other proteases in vitro contributed to generation of angiotensin peptides ( at that time these were used to measure renin activity).  This work demonstrated that accuracy in measuring renin using its enzymatic capability, was influenced by the pH of the renin-angiotensinogen reaction.  Interestingly, the renal clearance of renin was shown to be greater in women than in men. Together, with Sandy and Malcolm Symonds, Eugenie showed that large amounts of renin are present in human amniotic fluid and renin is present in human fetal membranes, decidua, myometrium and placenta. She measured maternal plasma renin and angiotensinogen levels throughout pregnancy describing their gestational profile. Eugenie and Sandy Skinner, showed that oral contraceptives caused a significant rise in circulating angiotensinogen levels, an oestrogenic effect and in a later clinical study she showed that oral contraceptives caused associated with a rise in blood pressure especially in women who had a family history of hypertension or of hypertension in pregnancy.
Eugenie then worked with RF Whelan and found that the sensitivity of the peripheral circulation of pregnant women to angiotensin II was reduced when compared with non pregnant women, but there was no effect of pregnancy on sensitivity to noradrenaline. This is the only publication showing  that the well described insensitivity of pregnant women to angiotensin II’s blood pressure raising effect is associated with decreased sensitivity of peripheral vascular angiotensin receptors to the peptide.


At this time, Eugenie discovered that renin in amniotic fluid and plasma was present in an inactive form, that could be activated by exposure to low pH. Together with an honours student, Brian Morris, she showed that ‘inactive’ renin, which today is known as prorenin, could also be activated by proteases such as trypsin and pepsin but not by carboxypeptidases. The recognition that prorenin was present in maternal blood in very large amounts in early pregnancy depended on this discovery. Prorenin/inactive renin is a key word currently for >60000 publications listed on Pub Med. Eugenie was responsible for managing the laboratory diagnosis of the third case in the world of a renin-secreting tumour which owing to the high circulating levels of renin was associated with hypertension. Removal of the tumour caused a fall in renin levels and normalisation of blood pressure.


Eugenie was among the first to study fetal cardiovascular and renal physiology, initially in her laboratory at University of Adelaide and subsequently in the Nuffield Institute for Medical Research, University of Oxford as a CJ Martin NHMRC Fellow. Returning to Australia to UNSW, in 1974, she undertook the education of medical and science undergraduates in physiology and pharmacology and set up her own laboratory, showing that the circulating renin-angiotensin system was more active in babies born by vaginal delivery than in babies born by caesarean section. Subsequent publications showed that fetal angiotensin I is converted to angiotensin II across the placenta and she measured the responses of maternal and fetal renin angiotensin systems to drug induced hypertension and hypotension. At this time, together with Andrew Stevens Eugenie established a chronically catheterised fetal sheep model to study fetal cardiovascular and renal physiology in the non anaesthetised fetus in utero. She trained both honours and doctoral students in fetal research.


Her laboratory was the first to show that i.v. angiotensin II inhibited the cardiac baroreflex through inhibition of the cardiac vagus and together with McCloskey and Potter demonstrated that these actions of angiotensin were due to central inhibition of efferent cardiac vagal activity. Vasopressin and cold were shown to stimulate the vagus, thus vasopressin offsets the actions of angiotensin II on the vagus; they also measured the  fetal cardiac vagal response to hypoxia.


A series of publications showed that changes in maternal fluid and electrolyte balance had profound effects on the fetus and on its renal function. She developed a method for calculating net fluid transfer to the fetal sheep and was the first to show that the fetal kidney can secrete protons in response to a metabolic acidosis and that renal function changes at birth. With Smith and Hill (now Gibson), Lumbers published further papers on the fetal response to maternal hyperglycaemia, changes in maternal fluid balance, cortisol, and birth and on the kidney’s ability to secrete organic acids and bases. 


Other areas of research included studies with Leo Leader on habituation by the fetus to vibroacoustic stimulation of the mother,  and the effects of alcohol on this response as well as measuring catecholamines released when the fetus is ‘startled’ by stimulation of the mother’s skin. 
While investigating the interrelationships between maternal and fetal fluid balance, maternal hypertension and uteroplacental blood flow, Eugenie found that administration of the angiotensin converting enzyme inhibitor (ACEI), captopril to the ewe, caused a fall in fetal blood pressure and complete cessation of fetal glomerular ultrafiltration which was restored by iv infusion of angiotensin II. This publication and others showed that the oligohydramnios seen in pregnant women given ACEIs or ARBs is due to loss of efferent arteriolar vascular tone necessary to maintain fetal which has an arterial pressure below the autoregulatory range. Other publications included work on the role of prostaglandins and vasopressin in fetal fluid and electrolyte balance and in renal function.


Working with Marelyn Wintour Coghlan, Lumbers discovered that cortisol enhanced the vascular reactivity of the fetal sheep to angiotensin II. Since cortisol plays a key role in preparing the fetus for birth, this publication is highly cited. Together with Jeff Segar, University of Iowa, she showed that in preterm lambs treatment with glucocorticoids was essential for the increase in renal sympathetic nerve activity associated with delivery and prenatal exposure to dexamethasone “programmed” the fetal cardiovascular system, so that is was altered in adult life. 


Other work studied angiotensin receptor subtypes in the maternal uterine vessels and in the fetal cardiovascular system. A particular finding was the observation that high levels of angiotensin II eliminated dilator AT2 receptors from the uterine arteries of pregnant ewes converting the vascular response of these vessels to a nonpregnant vasoconstrictor profile.


Other studies carried out at this time with Amanda Marsh (now Boyce) established in further detail the influence of growth factors, amino acids, asphyxia on the developing kidney and a series of experiments that showed that impaired maternal renal function (induced by prepregnancy subtotal nephrectomy of the ewe) had marked effects on the composition of fetal and maternal plasma, on fetal renal function, on the postnatal morphology of the kidney and impaired the response the lambs renal responses to salt and haemorrhage in adult life. This work contributed to the impetus of fetal programming in the aetiology of chronic disease in adult life and this impairment of programmed functional renal responses may well underpin the role of the kidney in hypertension and cardiovascular disease in adult life.


This led to Lumbers’ involvement (after 2008) in the effects of maternal health in Indigenous communities and the effects of prematurity on renal development of the term and preterm indigenous infant as well as the genetic differences in expression of components of the renin-angiotensin system in Indigenous and non-indigenous communities (163).  A unique contribution to understanding of the RAS in pregnancy was the work on the intrarenal RAS in healthy non pregnant individuals and in pregnant indigenous women.


Other projects at this time, looked at fetal cardiomyocyte maturation which paved the way for later studies (after 2008) on the maturation of the fetal pig heart and circulation with Paul Colditz, Barbara Lingwood and Yvonne Eiby at UQ. 


As well Eugenie began studies on the effects of fetal behaviour on renal sympathetic nerve activity and on decomposition of heart rate variability in fetus and newborn using Fast Fourier Transform in order to isolate the interaction of the sympathetic nerves and the vagus in controlling fetal and newborn heart rates. In the newborn the high heart rate appears to be caused by high levels of circulating catecholamines and the only significant modulator of neonatal heart rate at this time is cardiac vagal activity.


From 2003 onwards, Lumbers did not do any significant research and from 2007 onwards only worked as a volunteer or on a fractional appointment (0.15% FTE, level E academic). 


Despite this she had developed (as stated above) research into Indigenous renal health (see above, in collaboration with Kandasarmy, Smith and Rae) and more significantly, in 2008 she began a collaboration with a young post-doc, Kirsty Pringle, at University of Newcastle, initially supported by a NHMRC grant awarded to Lumbers, Hirst and Zakar to study the role of the newly discovered prorenin receptor and the renin-angiotensin system in maintenance of pregnancy. She collaborated with Dekker and Roberts to look early in pregnancy for RAS biomarkers that might predict pregnancy complications. Two publications, measured the proteins of the RAS in urine and in particular angiotensinogen as a marker of renal dysfunction in pregnancy in Indigenous women. 


The following publications are the result of the collaboration between Lumbers and Pringle in studying the roles of the intrarenal RAS and the prorenin receptor in placental growth and development with particular emphasis on regulation of the placental RAS and its functional effects. Kirsty now plays the major role in managing the research program. Our work has expanded to studies on the role of the RAS in growth and spread of endometrial cancer and in preterm birth. We have shown for the first time that the prorenin receptor is highly expressed in human intrauterine tissues,  we have studied the effects on the decidual and placental RASs of cyclic AMP, oxygen, fetal sex, hypomethylation and miRNAs. Currently we are focussing on the role of the prorenin receptor in placentogenesis (research funded by Pringle’s ARC’s Fellowship), soluble prorenin receptor as a biomarker for pregnancy associated complications, the role of the prorenin receptor in spread of endometrial cancer and the role of miRNAs in regulation of the placental RAS.

 

MAJOR FUNDING SUPPORT: In 1974 Lumbers began work as a Senior lecturer at UNSW; getting her first NHMRC grant in 1975. She continuously held 1 or more NHMRC grants up to and including 2003. Over the same period she had NHF, ARC and AKF support. She was a CI on 3 current NHMRC grants that expired in 2011. She is currently CIC on 4 NHMRC projects 1) 2 commenced in 2012; one finishes at the end of 2014 ; 2) she is CIA on another 2013-2015 and 3)  CIB on one 2014-2016. She has also been awarded research support by University of Newcastle and HMRI.

 

PUBLICATIONS: 179 publications; 145 papers in refereed journals; 34 other: reviews, book chapters and other writings, co-author of >350 abstracts; Citation report: H-index =32, Citation count: 3864; average citation count 20.2, citation count p.a.84; 3>200,6>100. In 2008, I initiated a new line of research after not working since Feb 2003, my yearly citation count was 74 that year; it rose to 101 in 2013 as my new research effort became productive (Web of science).

 

Plenary, Keynote and invited talks:

 

Within Australia University of Sydney, University of Melbourne, Monash University and Adelaide University.

 

Overseas; 

USA: University of California (Harbor, San Diego), Cornell University, University of Iowa, The University of Pennsylvania, University of Health Sciences (Portland, Oregon), Downstate Medical Centre, NY, Southwestern University, Dallas, Texas.

UK: The University of Cambridge, Oxford University, Southampton University, Nottingham University. 

Other: Universiti Sains (Malaysia); University of Auckland; Beijing Medical University, Beijing; Astra Pain Control, Stockholm; Harbin First Medical College, Harbin (China); Erasmus Medical College, Rotterdam; University of Southern Denmark, Odense. Invited Speaker; Since 2007 I have had 6 national/international invitations to speak with costs partly defrayed (2 in 2013).

 

COMMUNITY ENGAGEMENT:

Scientists in Schools (CSIRO); community groups, media on animal based research and on medical research.

 

PEER REVIEW AND DISCIPLINE INVOLVEMENT: 

Editorial boards; refere(ed) for Circulation Research, MJA, CEPP, AJP, J Physiol,, J Dev Physiol, Ped Res, Anat Rec Hypertension, Placenta, Reproduction and Fertility. PLos (one), DOHAD J. Acta Physiologic Scand.

 

Research Expertise
Eugenie Lumbers has a national and international profile since her discovery of prorenin. Lumbers made significant discoveries in adult and fetal cardiovascular physiology on inhibition of the vagal component of the cardiac baroreflex by angiotensin, the fetal cardiovascular effects of cortisol and in her work in fetal cardiovascular physiology and renal function (with particular reference to the renin-angiotensin system). She has studied fetal programming i.e. the impact of maternal renal dysfunction on fetal renal development. She is widely known to a range of medical scientists in the USA and UK.

 

In 2008 she began work on the role(s) of the human intrauterine renin angiotensin system (RAS). She has developed collaborations with Professor Claire Roberts, Gus Dekker (U Adel) and Professor Fiona Broughton Pipkin, Nottingham (U Nottingham) and with Professor Paul Colditz and Dr Barbara Lingwood (UQ), Professor Roger Smith AM (Indigenous renal health) and Professor Rodney Scott (U Newcastle) the RAS and endometrial cancer and Professor Caroline Blackwell (inflammation and chronic disease in Indigenous Australians.

 

• NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL

• Member of Regional Grants Interviewing Committees which visited Melbourne (1979, 1982, 1984, 1985, 1989, 1994, 1995 and 1996) and Brisbane (1988).

• In 1989, I spoke at public meetings on the NH&MRC case for funds.

• Member of the NHMRC Quinquennial Review Committee which reviewed the Howard Florey Institute, Melbourne (1989).

• Appreciator for NHMRC Triennial Review (1990). Member of the committee that reviewed NH&MRC for the Minister for Community Services and Health (1990).

• Assessor for project grant applications (1980 - present).

• Member of NH&MRC Careers and Awards Committee (1989 - 1993).

• NHMRC representative on the Appointment and Promotions Committee for Baker Medical Research Institute (1991 - present).

• Member of Assigner’s Panel (1991, 1994 -1998).

• Member of the NHMRC Quinquennial Review Committee which reviewed the Howard Florey (1991) and the Baker Medical Research Institute (1992).

• Member of NHMRC Fellowship Committee (1993).

• Chair, NHMRC RGIC, Melbourne (1994 - 1996). • Member of NHMRC Grants Committee (1994 - 1996).

• Member of NHMRC Medical Research Council (1994 - 1996).

• Regional Chair, NHMRC, site visit NRCET (1995).

• Member of Quinnquenial Review Committee for Howard Florey Institute (1997).

• Member of NHMRC Discipline Panel (2001-2002).

• Member NHMRC GRP3b (2007). NATIONAL HEART FOUNDATION

• Assessor for project grant applications and program grants (1984 - 1995).

• Member of NSW National Heart Foundation Scientific Advisory Committee (1983 - present).

• Member of the National Heart Foundation Interviewing Committee which visited Perth and Adelaide (1985), Adelaide (1986), Brisbane and Adelaide (1986), Melbourne and Adelaide (1987).

• Member of National Heart Fellowships Committee (1988 - 1989).

• Chair, NHF Regional Grants Committee (1992).

• National Cardiovascular Advisory Committee member (1997-2002).

• Presiding member of Scientific Advisory Committee of NSW division of NHF (1997- 2002).

• AUSTRALIAN RESEARCH COUNCIL

• ARC Biological Sciences Discipline Panel (1999 - 2000). NEW ZEALAND HEALTH RESEARCH COUNCIL

• Project grants committee (2002, 2005) 

Teaching Expertise
UNDERGRADUATE TEACHING:

Medical and Science students in physiology and pharmacology from 1974-2003.

Lecturer to medical or science students at U Newcastle and UNSW.

 

MENTORING AND RESEARCH TRAINING:

ERL has successfully supervised 23 honors students and 18 PhD students.

Currently she is cosupervising 1 PhD student and 1 honors student and mentoring 1 BMedSci student.

 

AUSTRALIAN MEDICAL COUNCIL

• Member of teams that accredited medical courses at the following universities: Flinders University (old course), Flinders University (new course), University of Queensland, James Cook University, University of Tasmania (2005). • Member, AMC Accreditation Committee (1997 - 1999). OTHERS • Course Accreditation Committees to Canberra CAE (1988 & 1989).

• Medical Appointment Advisory Committee for the Royal Hospital for Women (1985 - 1989).

• PhD Advisory Committee, School of Applied Science, University of Canberra (1989).

• Course Accreditation Committee for University of Canberra Bachelor of Nursing course, Canberra (1991).

• Review Faculty of Science UTS (1995).

• Reviewer for Dr J Faber's program grant at the University of Health Sciences, Portland, Oregon.

• Member of Management Committee for CRC (Biopharmaceuticals) from 1992 - 2000.

• Member of Committee that reviewed the Department of Obstetrics and Gynecology. The University of Sydney (1993).

• Prime Minister's Advisory Committee for Women in Science, Engineering and Technology (1993).

• Member of the Academy of Science National Committee for Physiology (1993 - 1999).

• Member of the Australian Perinatal Society Programme Resource Committee (1993 - 1995).

• Member of WISET Advisory Group (1994 - 1995).

• Member of New Zealand Health Research Council to visit Gluckman Programme, University of Auckland (1994), member of Physiology Assessment Committee (1994).

• Research Advisory Committee, Prince of Wales Children Research Foundation (1990- 2002).

• Member of the Research and Executive Committee of the Australian Society for Medical Research (ASMR) Research Fund (1994- 2002).

• Consultant DEET & DEEWR 2006, 2007, 2008.

• I have assisted the Academy of Science in appraisal of scholarships and grants 

Administrative Expertise
• Head of School of physiology and Pharmacology UNSW 1991-1999 Other General 

• Member of the UNSW Animal Breeding and Holding Unit Management Committee (1981 - 1983)

• Chairman of the UNSW Animal Breeding and Holding Unit Management Committee (1984 - 1987).

• Member of the Advisory Committee for the UNSW Animal Breeding and Holding Unit (1987).

• Member of the UNSW Committee for the Use of Animals in Research and Teaching (1983 - 1987).

• Member of Selection Committees for Appointment of Academic Staff to the Faculty of Military Studies, Medicine, Professional Studies, and others (1984 - 1987).

• Elected to the UNSW Council (1986 - 1996).

• Member of Buildings and Equipment Committee of UNSW Council (1986 - 1990).

• Member of the Academic Committee of UNSW Council (1988 - 1990).

• Presiding Member of Women Academic's Group (1989).

• Elected as representative of the Academic Staff to the UNSW Council (1990 - 1991; 1994-1996).

• Presiding Member of Student Affairs Committee of UNSW Council (1990 - 1996).

• Member of EEO & Advisory Committee of Council (1989 - 1992).

• Member of Committee of the Review Committee the School of Community Medicine, UNSW (May, 1993).

• Chair UNSW Child-Care Support Fund (from inception until 2002).

• Elected Member of Academic Board (1994 - 1996).

• Elected Member of the Academic Board, May 2001-June 2002.

• Member of Research Committee, Academic Board , UNSW, February, 2002- June 2002. Faculty

• Member of the Faculty of Medicine Promotions Committee (1987 - 1995).

• Member of the Executive Committee of the Faculty of Medicine (1980 - 1985; 1991).

• Year 3 New Curriculum Subcommittee for the 6 year medical course (1987).

• Member of Higher Degree Committee (1987).

• Member of Faculty of Medicine Academic Promotions to Professor and Associate Professor Committee (1991 onwards).

• Member of Faculty of Medicine Honours and Postgraduate Course Committee (1991- 1997).

• Member of Faculty of Medicine Research Advisory Committee (1991 - present).

• Member of Faculty of Medicine Dean's Advisory Committee (1991 - 1998).

• Representative for UNSW Faculty of Medicine in International Medical College meeting, Malaysia (1992).

• Postgraduate Coordinator for the School of Physiology and Pharmacology (1992 - 1995).

• Member of Faculty Research Committee (2001-2002).

• Research Coordinator School of Medical Sciences (2002). Boards

• National Heart Foundation, NSW Division (1997-2002)

• Heart Research Institute (representing the NHF)

• Elected Member of ANZCCART Board (1993 - 1995)

• Board member of ANZCCART as representative of the ARC (1999-2000) 

Collaborations
Current collaborations with Professor Claire Roberts, Gus Dekker (U Adel) and Professor Fiona Broughton Pipkin, Nottingham (U Nottingham) and with Professor Paul Colditz and Dr Barbara Lingwood (UQ), Professor Roger Smith AM (Indigenous renal health) and Professor Rodney Scott (U Newcastle) the RAS and endometrial cancer, Professoer caroline Balckwell (inflammation and cardiovascular and renal disease). Professor Brina Morris (U Syd) RAS.

 

Research Expertise: renal; maternal; neonatal; placenta; hypertension; reproductive; cardiovascular; medical physiology; maternal physiology; medical pharmacology; renin angiotensin system; fetal origins of adult disease; fetal cardiovascular and renal phsyiology; fetal

UNIVERSITY OF NEWCASTLE APPOINTMENTS

  • Honorary Professor
    University of Newcastle, School of Biomedical Sciences and Pharmacy, Australia18 Jan 2021 - present

ACADEMIC POSITIONS

  • Professor
    The University of Newcastle, School of Biomedical Sciences, Australia1 Jan 2009 - present
  • Professor
    The University of Queensland, UQ Centre for Clinical Research (UQCCR), Australia1 Jan 2009 - present
  • Professor
    The University of Newcastle, School of Biomedical Sciences and Pharmacy, Australia1 Jan 2007 - 1 Dec 2008
  • Consultant
    The University of Adelaide, School of Women and Child Health, Australia1 Jan 2006 - present
  • Emeritus Scientia Professor
    The University of New South Wales, Australia1 Feb 2003 - present
  • Scientia Professor
    The University of New South Wales, School of Physiology and Pharmacology, Australia1 Jan 1999 - 1 Feb 2003
  • Professor
    The University of New South Wales, School of Physiology and Pharmacology, Australia1 Jan 1988 - 1 Dec 1999
  • Visiting Professor
    Univeristy of California San Fancisco, United States1 Jan 1980 - 1 Jul 1980
  • Associate Professor
    The University of New South Wales, School of Physiology and Pharmacology, Australia1 Jan 1980 - 1 Dec 1988
  • Senior Lecturer
    The University of New South Wales, School of Physiology and Pharmacology, Australia1 Jan 1974 - 1 Dec 1979
  • CJ Martin Fellow
    Oxford University, UK, Nuffield Institute for Medical Research, United Kingdom1 Jan 1972 - 1 Dec 1973
  • NHMRC Senior Research Officer
    The University of Adelaide, Physiology, Australia1 Jan 1970 - 1 Dec 1971
  • Postgraduate Medical Scholar
    The University of Adelaide, National Health and Medical Research Council (NHMRC), Australia1 Jan 1966 - 1 Dec 1969

DEGREES

  • Doctor of Science
    University of New South Wales, Australia17 Oct 1986
  • Bachelor of Medicine Bachelor of Surgery
    University of Adelaide, Australia14 Apr 1965
  • Doctor of Medicine
    University of Adelaide, Australia5 May 1971

PROFILE TYPE

  • Conjoint

SUSTAINABLE DEVELOPMENT GOALS

  • 4 Quality Education
  • 3 Good Health and Well Being
  • 5 Gender Equality

DISCIPLINE

  • Pharmacy and Experimental Pharmacology